News
-
Biophytis confirme le lancement de l’essai clinique de Phase 2 OBA dans l’obésité
-
Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
-
Thales makes available its Universal Registration Document 2024
-
Thales met à disposition son Document d’Enregistrement Universel 2024
-
Availability of the preparatory documents for the combined General Meeting of 29 April 2025
-
RTG Mining Inc. Announces Issue Of A$4.2 million Chess Depository Instruments Under Placement
-
QNX Now Powering WeRide's Next-Generation ADAS Platform
-
MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025
-
Forte Group Announces Strategic Initiatives to Strengthen Financial Position
-
Gladstone Commercial Corporation Announces Monthly Cash Distributions for April, May and June 2025 and Earnings Release and Conference Call Dates for its First Quarter Ended March 31, 2025
-
Leifheit AG: Significant increase in profitability in the 2024 financial year
-
Sensirion opens additional production building in Debrecen
-
Iute Group Starts Conditional Exchange And Cash Tender Offer For New EUR 2025/2030 Bonds
-
Press release: Leonteq enters the market for listed leverage products in Switzerland
-
ARYZTA issues AGM invitation